Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHG.L Regulatory News (GHG)

  • There is currently no data for GHG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Georgia Healthcare Group PC

29 Apr 2020 11:36

RNS Number : 3310L
Georgia Capital PLC
29 April 2020
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Georgia Capital plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Georgia Healthcare Group plc

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

28 April 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes, in relation to the relevant securities of the offeror, Georgia Capital PLC

:

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Georgia Healthcare Group plc

 

Class of relevant security:

 

Ordinary shares of 1 pence each in Georgia Healthcare Group PLC

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

93,011,414

70.63

 

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

TOTAL:

93,011,414

70.63

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

 

(a) Interests of the directors of Georgia Capital PLC in the ordinary shares of 1 pence each held directly in Georgia Healthcare Group PLC:

 

 

Director:

Number of ordinary shares held directly

% of total issued share capital of Georgia Healthcare Group PLC

Irakli Gilauri

231,566

0.18

Kim Bradley

10,687

0.01

David Morrison

65,583

0.05

 

(b) Interests of the directors of Georgia Capital PLC in the ordinary shares of 1 pence each in Georgia Healthcare Group PLC held through Georgia Healthcare Group PLC's share plan:

 

None

 

(c) Interests in the ordinary shares of 1 pence each in Georgia Healthcare Group PLC held by other persons acting in concert with Georgia Capital PLC:

 

None

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

28 April 2020

Contact name:

Levan Dadiani

Telephone number:

+995 599 516467

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEUKORRRSUSUAR
Date   Source Headline
24th Oct 20167:00 amRNSGHG launches a new ambulatory cluster
10th Oct 20167:00 amRNSGHG Investor Day Notice
12th Sep 20167:00 amRNSGHG signs loan agreement with IFC
24th Aug 20167:00 amRNSGHG launches a new ambulatory cluster in Tbilisi
15th Aug 20167:00 amRNSHalf-year Report
11th Aug 20167:00 amRNSGHG signs loan agreement with Proparco
11th Aug 20167:00 amRNSNotice of Results
9th Aug 20167:00 amRNSGHG launches outpatient and diagnostic centres
8th Aug 20167:00 amRNSSave the date GHG investor day 23 November
1st Aug 20167:00 amRNSGHG launches a new ambulatory cluster in Tbilisi
27th Jul 20164:40 pmRNSSecond Price Monitoring Extn
27th Jul 20164:35 pmRNSPrice Monitoring Extension
20th Jul 20167:00 amRNSGHG announces appointment of corporate brokers
28th Jun 20163:10 pmRNSDirector/PDMR Shareholding
13th Jun 20167:00 amRNSGHG announces appointment of CEO of Imedi L
26th May 20164:26 pmRNSResult of AGM
17th May 20167:00 amRNS1st Quarter Results
16th May 20167:00 amRNSGHG launches a new ambulatory cluster in Tbilisi
13th May 20167:03 amRNSNotice of the first quarter 2016 results
5th May 20167:03 amRNSHealthcare subsidiary completes acquisition of GPC
5th May 20167:00 amRNSGHG announces completion of the acquisition of GPC
25th Apr 20162:16 pmRNSNotice of AGM
14th Apr 20165:58 pmRNSHolding(s) in Company
14th Apr 20167:51 amRNSLaunch of In Vitro Fertilisation service
13th Apr 20165:36 pmRNSHolding(s) in Company
8th Apr 20165:35 pmRNSAnnual Financial Report
7th Apr 20165:37 pmRNSDirector/PDMR Shareholding
16th Mar 20167:04 amRNSGHG announces appointment of Deputy CEO
16th Mar 20167:00 amRNSAcquisition
23rd Feb 20167:00 amRNSGHG buys out minority at major referral hospital
15th Feb 20167:00 amRNSFinal Results
11th Feb 20163:20 pmRNSNotice of Q4 and Full Year Results
13th Jan 20165:29 pmRNSGHG's Reduction of Capital becomes effective
13th Jan 20167:00 amRNSGHG appoint Chief Clinical Officer
30th Dec 20157:00 amRNSGHG launches two ambulatory clusters
23rd Nov 201510:03 amRNSGHG Q3 results announced as part of BGEO's results
23rd Nov 20157:01 amRNSGeorgia Healthcare Group - Stabilisation Notice
12th Nov 20152:38 pmRNSGHG announces Admission to Trading
9th Nov 20155:36 pmRNSPublication of Prospectus
9th Nov 20157:46 amRNSGHG Prospectus Publication correction
9th Nov 20157:16 amRNSStabilisation Notice
9th Nov 20157:00 amRNSPublication of Prospectus
9th Nov 20157:00 amRNSGHG announces the Offering Price for its IPO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.